Specific viral antibodies associate with anti-NMDAR encephalitis after herpes simplex encephalitis
Year: 2025
Type: article
Study design: Observational Study
Abstract: Herpes simplex encephalitis (HSE) patients may develop secondary anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis (NMDARE), associated with worsened long-term neurological outcome. Immunosuppressive treatment can limit NMDAR autoantibody-mediated pathology, but early predictive biomarkers for the risk of NMDARE are lacking. In a multicenter study, we performed unbiased antibody reactome profiling using Phage ImmunoPrecipitation Sequencing (PhIP-Seq). HSE patients with secondary NMDARE (n = 13) versus those without (n = 10) showed enhanced antibody responses against HSV-1, but not HSV-2, which comprised specific antibodies to five peptides of the HSV-1 UL42 and UL48 proteins. A score of these signature CSF antibodies identified HSE patients with secondary NMDARE with a sensitivity of 75%, a specificity of > 99%, a positive predictive value of 90%, a negative predictive value of > 97% and an odds ratio (OR) of 209 (CI: 28 - 1,582) across all individuals in this study, and with similar performance values in serum (>66%, >99%, >88%, >96%, OR 307 (15 - 6,089)). These signature antibodies represent a promising biomarker to identify HSE patients at risk for NMDARE development. In NMDARE patients without a history of HSE and in MS patients, no disease-associated HSV antibody reactivity patterns were detected. Furthermore, we introduced the Multiplexed Index Calculations of the Antibody Reactome (MICAR) metric to characterize proteomic targets of compartment-specific antibody responses, an approach that is applicable in neuroimmunology and other compartmentalized disease states.
Source: Brain Behavior and Immunity
Authors: Jakob Kreye, William R. Morgenlander, Manjusha Thakar, Poul M. Schulte-Frankenfeld, Sarah Schott, Isabel Bünger, Hans-Christian Kornau, Julia W. Angkeow, Sahana Jayaraman, Carolin Otto, Wiebke Hahn, Jan Lewerenz, Franziska S. Thaler, Mirjam Korporal-Kuhnke, Nico Melzer, Justina Dargvainiene, Christian G. Bien, Rose Kohlie, Erik Lattwein, Dietmar Schmitz, Peter A. Calabresi, Carlos A. Pardo, Harald Prüss, Klemens Ruprecht, H. Benjamin Larman
Institutions: Johns Hopkins University, German Center for Neurodegenerative Diseases, Humboldt-Universität zu Berlin, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charité – Universitätsmedizin Berlin, Freie Universität Berlin, Philipps University of Marburg, Universität Ulm, LMU Klinikum, Institut für Klinische Neuroimmunologie, Ludwig-Maximilians-Universität München, Heidelberg University, Düsseldorf University Hospital, Heinrich Heine University Düsseldorf, Christian-Albrechts-Universität zu Kiel, University Hospital Schleswig-Holstein, Bielefeld University, Laboratory Krone, Krankenhaus Mara, Euroimmun Medizinische Labordiagnostika (Germany), Johns Hopkins Medicine
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,680
Funders: Helmholtz-Gemeinschaft, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Helmholtz Association, Berlin Institute of Health, National Institutes of Health, National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke, German-American Fulbright Program
Awards: G1380736555, Design and Analysis of Displayed Peptidomes, CONNECT-GENERATE - Deutsches Netzwerk zur Erforschung autoimmuner Enzephalitiden - Teilprojekt 1 Register, Teilprojekt 3 Genetische Ursachen, OPTIMIZATION AND ASSESSMENT OF A BIOLOGIC TO IMPROVE FUNCTIONAL RECOVERY AFTER PERIPHERAL NERVE INJURY, G464521655, CONNECT-GENERATE 2.0 - Forschungsverbund zur Aufklärung, Kategorisierung und Behandlung autoimmuner Hirnentzündungen und verwandter Erkrankungen - Koordination, Register und genetische Analysen, CONNECT-GENERATE 2.0 - Forschungsverbund zur Aufklärung, Kategorisierung und Behandlung autoimmuner Hirnentzündungen und verwandter Erkrankungen - Identifizierung neuer Autoantikörper und Quantitatives MRT, Emerging Neuroviruses and Neurological Inflammatory Diseases, CONNECT-GENERATE - Deutsches Netzwerk zur Erforschung autoimmuner Enzephalitiden - Teilprojekt 2 Biobank, CONNECT-GENERATE - Deutsches Netzwerk zur Erforschung autoimmuner Enzephalitiden - Teilprojekt 4 Autoantikörper, Teilprojekt 6 MRT-Bildgebung, Neurosarcoidosis: Clinical Phenotype, Biomarkers and Immunopathogensis
OpenAlex ID: W4413117203
